Microbot Medical
MBOT
29 hedge funds and large institutions have $910K invested in Microbot Medical in 2018 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 11 increasing their positions, 4 reducing their positions, and 8 closing their positions.
175% more repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 4
131% more capital inflows, than outflows
Capital inflows: $452K | Capital outflows: $196K
38% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 8
12% more funds holding
Funds holding: 26 → 29 (+3)
1.18% more ownership
Funds ownership: 3.02% → 4.19% (+1.2%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
+$186K |
| 2 |
Dimensional Fund Advisors
Austin,
Texas
|
+$115K |
| 3 |
Barclays
London,
United Kingdom
|
+$91.5K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$56.3K |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$3K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Virtu Financial
New York
|
-$57K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$46K |
| 3 |
Zeke Capital Advisors
Berwyn,
Pennsylvania
|
-$30K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
-$26K |
| 5 |
Northern Trust
Chicago,
Illinois
|
-$11K |
MBOT Hedge Fund Activity: Q3 2018 in Review
29 of the 4,392 institutional investors tracked by Wall St. Rank reported a position in Microbot Medical (MBOT) for Q3 2018, worth a combined $910K — down 6.6% from $974K a quarter earlier.
Buyers outnumbered sellers: 11 funds opened new MBOT positions and 8 closed out — a net gain of 3 holders — while 11 added to existing stakes and 4 trimmed.
The largest buyer was Sabby Management, adding an estimated $186K. The largest seller was Virtu Financial, exiting entirely with an estimated $57K sold.
- 29 institutional investors held Microbot Medical (MBOT) as of Q3 2018, up from 26 in Q2 2018.
- Funds reported $910K of Microbot Medical stock for Q3 2018, down 6.6% quarter-over-quarter.
- 11 funds opened new Microbot Medical positions in Q3 2018 and 8 closed out, a net change of +3 holders.
- The largest Microbot Medical buyer in Q3 2018 was Sabby Management, an estimated $186K added.
- The largest Microbot Medical seller in Q3 2018 was Virtu Financial, an estimated $57K sold.
Based on aggregated 13F filings for Q3 2018.